CAR-T therapy could treat severe autoimmune diseases, shows study

Catherine Eckford2026-04-09T16:01:00

Source:

Earlier intervention in severe autoimmune diseases may help prevent complications following previous ineffective treatments.

For the first time, a CD19 CAR-T cell therapy has shown high efficiency in managing three different severe autoimmune diseases.

The study, conducted on one female patient, demonstrated achievement of remission, with no further treatment required a year on after being given the cell therapy.

These results offer significant potential in this indication because

Already a member? Sign-in

Unlock

Driving innovation in pharma manufacturing

European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.

Become a member to continue reading

By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:

Unlimited access to industry intelligence that can make a difference to your business
A weekly newsletter keeping the most vital information at the front of your thinking
Exclusive invitations to powerful webinars and events featuring high profile experts
Access to deep-dive reports and analysis that reveal exciting new opportunities for business growth and transformation

Become a member